Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106685404 | 10668540 | 4 | F | 20121026 | 20160728 | 20141222 | 20160809 | EXP | PHHO2014JP016768 | NOVARTIS | 74.19 | YR | F | Y | 56.00000 | KG | 20160809 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106685404 | 10668540 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 500 MG, QD | 201937.5 | MG | 22068 | 500 | MG | CAPSULE | QD | ||||
| 106685404 | 10668540 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 500 MG, QD | 201937.5 | MG | 22068 | 500 | MG | CAPSULE | QD | ||||
| 106685404 | 10668540 | 3 | SS | PURSENNIDE | SENNOSIDES A AND B | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 106685404 | 10668540 | 4 | C | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | UNK | 0 | ||||||||||
| 106685404 | 10668540 | 5 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Oral | UNK | 0 | ||||||||||
| 106685404 | 10668540 | 6 | C | DEPAS | ETIZOLAM | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106685404 | 10668540 | 1 | Chronic myeloid leukaemia |
| 106685404 | 10668540 | 3 | Product used for unknown indication |
| 106685404 | 10668540 | 4 | Product used for unknown indication |
| 106685404 | 10668540 | 5 | Product used for unknown indication |
| 106685404 | 10668540 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106685404 | 10668540 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106685404 | 10668540 | Blood triglycerides increased | |
| 106685404 | 10668540 | Hypoalbuminaemia | |
| 106685404 | 10668540 | Leukocytosis | |
| 106685404 | 10668540 | Low density lipoprotein increased | |
| 106685404 | 10668540 | Myocardial infarction | |
| 106685404 | 10668540 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106685404 | 10668540 | 1 | 20110920 | 20121027 | 0 | |
| 106685404 | 10668540 | 2 | 20130118 | 20131024 | 0 |